8-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]-7-[(2-fluorophenyl)methyl]-3-methylpurine-2,6-dione
C27H32FN7O2 — CID 155410051
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]-7-[(2-fluorophenyl)methyl]-3-methylpurine-2,6-dione
8-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]-7-[(2-fluorophenyl)methyl]-3-methylpurine-2,6-dione (PubChem CID 155410051) has the molecular formula C27H32FN7O2 and a molecular weight of 505.60 g/mol. Its IUPAC name is 8-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]-7-[(2-fluorophenyl)methyl]-3-methylpurine-2,6-dione.
Molecular Properties
| Compound Name | 8-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]-7-[(2-fluorophenyl)methyl]-3-methylpurine-2,6-dione |
|---|---|
| PubChem CID | 155410051 |
| Molecular Formula | C27H32FN7O2 |
| Molecular Weight | 505.60 g/mol |
| Exact Mass | 505.26 |
| IUPAC Name | 8-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]-7-[(2-fluorophenyl)methyl]-3-methylpurine-2,6-dione |
| SMILES | Cn1c(=O)[nH]c(=O)c2c1nc(N1CCN(Cc3ccc(C(C)(C)C)nc3)CC1)n2Cc1ccccc1F |
| InChI | InChI=1S/C27H32FN7O2/c1-27(2,3)21-10-9-18(15-29-21)16-33-11-13-34(14-12-33)25-30-23-22(24(36)31-26(37)32(23)4)35(25)17-19-7-5-6-8-20(19)28/h5-10,15H,11-14,16-17H2,1-4H3,(H,31,36,37) |
| InChIKey | NFVICABWUGZHQF-UHFFFAOYSA-N |
| XLogP | 2.63 |
| TPSA | 92.05 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 505.60 |
| LogP ≤ 5 | 2.63 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155410051 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.